CC
Publications
123
Views
61,737
Downloads
16,725
Supervised works
7
Items per page
1 - 123 of 123
Title Published in Access level OA Policy Year Views Downloads
Extrafollicular CD19lowCXCR5CD11c double negative 3 (DN3) B cells are significantly associated with disease activity in females with systemic lupus erythematosusJournal of translational autoimmunity
accessLevelPublic
2024 80 38
IL-25 participates in keratinocyte-driven dermal matrix turnover and is reduced in systemic sclerosis epidermisRheumatology
accessLevelRestricted
2022 282 5
Urinary incontinence in systemic sclerosis: a prospective multicentre cohort studyRheumatology international
accessLevelPublic
2022 132 46
Dysfunctional keratinocytes increase dermal inflammation in systemic sclerosis. Results from tissue-engineered scleroderma epidermisArthritis and Rheumatology
accessLevelPublic
2021 383 282
Native/citrullinated LL37-specific T-cells help autoantibody production in systemic lupus erythematosusScientific Reports
accessLevelPublic
2020 318 133
Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohortRheumatology
accessLevelRestricted
2020 278 0
RB139, RB140, RB141 and RB142 antibodies recognize human citrullinated LL37 by ELISAAntibody Reports
accessLevelPublic
2020 258 150
RB137 recognizes LL37 in neutrophil-extracellular trap-like (NET) structures in systemic lupus erythematosus and rheumatoid arthritis inflamed tissues by immunofluorescence in histological sectionsAntibody reports
accessLevelPublic
2020 159 45
Identification of highly active systemic lupus erythematosus by combined type I interferon and neutrophil gene scores vs classical serologic markersRheumatology
accessLevelRestricted
2020 310 0
Monoclonal antibodies RB139 and RB142 recognize citrullinated LL37 by immunofluorescence in histological sections in Systemic lupus erythematosus (SLE) and Rheumatoid arthritis (RA)Antibody reports
accessLevelPublic
2020 166 47
IL-17A Dissociates Inflammation from Fibrogenesis in Systemic SclerosisJournal of Investigative Dermatology
accessLevelRestricted
2020 359 2
RB137 and RB138 antibodies recognize human cathelicidin LL37 by ELISAAntibody Reports
accessLevelPublic
2020 337 122
Quand penser à une myosite et quelle attitude adopter ?Revue médicale suisse
accessLevelPublic
2019 355 356
Susceptibility of BAFF-var allele carriers to severe SLE with occurrence of lupus nephritisBMC Nephrology
accessLevelPublic
2019 325 140
Molecular characterization of monocyte subsets reveals specific and distinctive molecular signatures associated with cardiovascular disease in rheumatoid arthritisFrontiers in Immunology
accessLevelPublic
2019 333 187
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort studyAnnals of the Rheumatic Diseases
accessLevelRestricted
2019 270 0
Treatment of calcinosis cutis in systemic sclerosis and dermatomyositis: a review of the literatureJournal of the American Academy of Dermatology
accessLevelPublic
2019 374 645
Anti-apolipoprotein A-1 autoantibodies correlate with disease activity in systemic lupus erythematosusRheumatology
accessLevelPublic
2019 437 207
Anti-C1q antibodies as occurring in systemic lupus erythematosus could be induced by an epstein-barr virus-derived antigenic siteFrontiers in Immunology
accessLevelPublic
2019 263 189
Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohortAnnals of the Rheumatic Diseases
accessLevelPublic
2019 337 147
CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α production in systemic sclerosisNature Communications
accessLevelPublic
2019 430 213
Phenotypes determined by cluster analysis and their survival in the prospective european scleroderma trials and research cohort of patients with systemic sclerosisArthritis and Rheumatology
accessLevelPublic
2019 265 218
Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysisAnnals of the Rheumatic Diseases
accessLevelPublic
2019 270 109
Racial differences in systemic sclerosis disease presentation: a european scleroderma trials and research group studyRheumatology
accessLevelRestricted
2019 288 0
Limbic encephalitis associated with systemic sclerosisMultiple Sclerosis and Related Disorders
accessLevelRestricted
2018 352 0
Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) databaseClinical and Experimental Rheumatology
accessLevelPublic
2018 309 271
Interleukin-6 and Type-I Collagen Production by Systemic Sclerosis Fibroblasts Are Differentially Regulated by Interleukin-17A in the Presence of Transforming Growth Factor-Beta 1Frontiers in Immunology
accessLevelPublic
2018 491 208
Prevalence, persistence and clinical correlations of classic and novel antiphospholipid antibodies in systemic lupus erythematosusRheumatology
accessLevelRestricted
2018 371 1
Prospective evaluation of the capillaroscopic skin ulcer risk index in systemic sclerosis patients in clinical practice: a longitudinal, multicentre studyArthritis Research and Therapy
accessLevelPublic
2018 366 184
Serum calcification propensity is independently associated with disease activity in systemic lupus erythematosusPLOS ONE
accessLevelPublic
2018 567 317
Association of antibodies against myelin and neuronal antigens with neuroinflammation in systemic lupus erythematosusRheumatology
accessLevelRestricted
2018 399 1
Allergologie et immunologie cliniqueRevue médicale suisse
accessLevelPublic
2018 536 145
Autoantibodies Against Albumin in Patients With Systemic Lupus ErythematosusFrontiers in Immunology
accessLevelPublic
2018 405 170
Chagas disease and systemic autoimmune diseases among Bolivian patients in SwitzerlandMemórias do Instituto Oswaldo Cruz
accessLevelPublic
2018 570 180
Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group StudyArthritis and Rheumatology
accessLevelRestricted
2018 270 0
Successful treatment of refractory lupus nephritis by the sequential use of rituximab and belimumabJoint bone spine
accessLevelRestricted
2017 629 1
Mesenteric inflammatory veno-occlusive disease of the spleen metasynchronous with two arterial thrombotic events in systemic lupus erythematosusLupus
accessLevelRestricted
2017 537 2
Prevalence and disease-specific risk factors for Lower Urinary Tract symptoms in Systemic Sclerosis: an international multi-centric studyArthritis Care and Research
2017 395 0
Matrix Metalloproteinases (MMPs) and cytokines in rheumatologyMatrix Metalloproteinases in health and disease. Sculpting the human body.
2017 297 0
Is there a role for IL-17 in the pathogenesis of systemic sclerosis?Immunology Letters
accessLevelRestricted
2017 447 1
The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre studyRheumatology
accessLevelRestricted
2017 537 0
Case Report: Masquerading Large-vessel Giant Cell ArteritisOptometry and Vision Science
accessLevelRestricted
2017 566 1
Impact of disease activity on health-related quality of life in systemic lupus erythematosus - a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS)BMC immunology
accessLevelPublic
2017 565 440
Basic mechanisms linking inflammation and fibrosisSystemic Fibroinflammatory Disorders
accessLevelRestricted
2017 320 0
Inflammation and immunityScleroderma: from pathogenesis to comprehensive management
accessLevelRestricted
2017 285 0
Immune complexes containing serum B-cell activating factor and immunoglobulin G correlate with disease activity in systemic lupus erythematosusNephrology, Dialysis, Transplantation
accessLevelRestricted
2017 494 0
Differential impact of systemic lupus erythematosus and rheumatoid arthritis on health-related quality of lifeQuality of life research
accessLevelRestricted
2017 502 1
Mapping and predicting mortality from systemic sclerosisAnnals of the Rheumatic Diseases
accessLevelRestricted
2017 377 1
An international SUrvey on non-iNvaSive tecHniques to assess the mIcrocirculation in patients with RayNaud's phEnomenon (SUNSHINE survey)Rheumatology International
accessLevelRestricted
2017 396 0
Keratinocyte-derived IL-17E contributes to inflammation in psoriasisJournal of investigative dermatology
accessLevelRestricted
2016 636 13
A 28-Year-Old Man Presenting With Intractable Dry Cough and a History of Ulcerative ColitisChest
accessLevelRestricted
2016 581 2
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective studyAnnals of the rheumatic diseases
accessLevelRestricted
2016 559 2
IL-22 capacitates dermal fibroblast responses to TNF in sclerodermaAnnals of the rheumatic diseases
accessLevelRestricted
2016 678 7
Sequential, Multimodal Treatment of a Refractory Adult-Onset Still's Disease Complicated by Reactive Hemophagocytic LymphohistiocytosisClinical medical reviews and case reports
accessLevelPublic
2016 415 166
Prevalence of vascular disease in systemic lupus erythematosus compared with type-1 diabetes mellitus: a cross-sectional study of two cohortsLupus
2015 524 0
Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR databaseAnnals of the rheumatic diseases
accessLevelRestricted
2015 424 1
Diagnostic Dilemma in Sequential Branch Retinal Vein and Artery OcclusionOptometry and vision science
accessLevelRestricted
2015 632 1
Restoration of hematopoiesis in a case of myelodysplastic syndrome associated with systemic lupus erythematosus treated with rituximabAnnals of hematology
accessLevelRestricted
2015 579 2
The role of the acquired immune response in systemic sclerosisSeminars in immunopathology
accessLevelRestricted
2015 428 0
Manifestations pulmonaires de la sclérodermie systémiqueRevue médicale suisse
accessLevelRestricted
2015 461 0
Vascularites systémiques : nouvelles nomenclature et approches thérapeutiquesRevue médicale suisse
accessLevelRestricted
2014 418 0
Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective studyAnnals of the rheumatic diseases
accessLevelRestricted
2014 404 0
[Renal disease in ANCA-associated vasculitis]Revue médicale suisse
accessLevelRestricted
2014 468 0
High IL-17E and low IL-17C dermal expression identifies a fibrosis-specific motif common to morphea and systemic sclerosisPloS one
accessLevelPublic
2014 690 310
The Swiss Systemic lupus erythematosus Cohort Study (SSCS) - cross-sectional analysis of clinical characteristics and treatments across different medical disciplines in SwitzerlandSchweizerische medizinische Wochenschrift
accessLevelPublic
2014 745 697
Manifestations digestives de la sclérodermieRevue médicale suisse
accessLevelRestricted
2014 417 0
Acquired factor XIII deficiency: a therapeutic challengeThrombosis and haemostasis
accessLevelRestricted
2013 624 0
Maladies auto-immunes neuromusculaires : diagnostic et prise en chargeRevue médicale suisse
accessLevelRestricted
2013 448 0
Rituximab in systemic lupus erythematosus: an updated systematic review and meta-analysisLupus
2013 581 0
Acute natural killer cell pneumonia in a patient transplanted with autologous haematopoietic stem cells for systemic sclerosisRheumatology
accessLevelRestricted
2013 606 0
Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblastsArthritis research & therapy
accessLevelPublic
2013 529 315
Interleukin-17A+ cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvementArthritis and rheumatism
accessLevelPublic
2013 627 483
Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group databaseAnnals of the rheumatic diseases
accessLevelRestricted
2012 572 0
Prostaglandin I(2) analogues enhance already exuberant Th17 cell responses in systemic sclerosisAnnals of the rheumatic diseases
accessLevelRestricted
2012 667 0
Interleukin-17 expression in neutrophils and Th17 cells in cutaneous T-cell lymphoma associated with neutrophilic infiltrate of the skinBritish journal of dermatology
accessLevelRestricted
2012 631 1
Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-upAnnals of the rheumatic diseases
accessLevelRestricted
2012 561 0
Response of mucocutaneous lesions to rituximab in a case of melanoma differentiation antigen 5-related dermatomyositisDermatology
accessLevelRestricted
2012 621 1
Cardiac involvement in Churg-Strauss syndrome mimicking acute coronary syndromeSchweizerische medizinische Wochenschrift
accessLevelRestricted
2012 651 0
T cell abnormalities in systemic sclerosis with a focus on Th17 cellsEuropean cytokine network
accessLevelRestricted
2012 506 0
Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung diseaseArthritis research & therapy
accessLevelPublic
2011 610 209
Hypereosinophilia in patients with multiple sclerosis treated with natalizumabNeurology
accessLevelRestricted
2011 701 0
Association of the CD226 Ser(307) variant with systemic sclerosis: evidence of a contribution of costimulation pathways in systemic sclerosis pathogenesisArthritis and rheumatism
accessLevelRestricted
2011 645 0
In vivo dioxin favors interleukin-22 production by human CD4+ T cells in an aryl hydrocarbon receptor (AhR)-dependent mannerPloS one
accessLevelPublic
2011 660 240
Absence of up-regulation for a proliferation-inducing ligand in Sjögren's sialadenitis lesionsRheumatology
accessLevelRestricted
2011 648 1
Late adult onset of Langerhans cell histiocytosis mimicking glioblastoma multiformeJournal of the neurological sciences
accessLevelRestricted
2011 617 0
Le risque cardiovasculaire dans les maladies auto-immunes systémiquesRevue médicale suisse
accessLevelRestricted
2011 574 0
Is there a role for TNFα antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi techniqueClinical and Experimental Rheumatology
accessLevelPublic
2011 494 882
Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cellsEuropean Journal of Immunology
accessLevelRestricted
2010 580 0
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) databaseJournal of rheumatology
accessLevelRestricted
2010 559 1
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) databaseAnnals of the rheumatic diseases
accessLevelRestricted
2010 503 1
Allergo-immunologieRevue médicale suisse
accessLevelRestricted
2010 518 0
CD56bright NK cells after hematopoietic stem cell transplantation are activated mature NK cells that expand in patients with low numbers of T cellsEuropean Journal of Immunology
accessLevelRestricted
2010 651 0
Transcriptional regulation of matrix metalloproteinase-1 and collagen 1A2 explains the anti-fibrotic effect exerted by proteasome inhibition in human dermal fibroblastsArthritis research & therapy
accessLevelPublic
2010 540 1,493
Prostaglandin E2: igniting the fireImmunology and cell biology
accessLevelRestricted
2009 488 0
Immunological determinants of clinical outcome in Peruvian patients with tegumentary leishmaniasis treated with pentavalent antimonialsInfection and immunity
accessLevelRestricted
2009 605 0
Synovial tissues concentrate secreted APRILArthritis research & therapy
accessLevelPublic
2009 627 354
In vivo investigations on anti-fibrotic potential of proteasome inhibition in lung and skin fibrosisAmerican journal of respiratory cell and molecular biology
accessLevelRestricted
2008 737 1
Antifibroblast antibodies in systemic sclerosis induce fibroblasts to produce profibrotic chemokines, with partial exploitation of toll-like receptor 4Arthritis and rheumatism
accessLevelRestricted
2008 637 0
Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansionBlood
accessLevelRestricted
2008 577 0
T cells, B cells, and polarized immune response in the pathogenesis of fibrosis and systemic sclerosisCurrent opinion in rheumatology
accessLevelRestricted
2008 570 0
APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosaThe Journal of clinical investigation
accessLevelPublic
2008 639 606
Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosisArthritis and rheumatism
accessLevelPublic
2007 552 360
Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group databaseAnnals of the rheumatic diseases
accessLevelPublic
2007 587 376
Cerebrospinal fluid anti-SSA autoantibodies in primary Sjogren's syndrome with central nervous system involvementEuropean neurology
accessLevelPublic
2007 1,802 474
Anti-fibroblast antibodies detected by cell-based ELISA in systemic sclerosis enhance the collagenolytic activity and matrix metalloproteinase-1 production in dermal fibroblastsRheumatology
accessLevelPublic
2007 467 235
Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodiesJournal of neurology, neurosurgery and psychiatry
accessLevelPublic
2007 497 443
Polarized subsets of human T-helper cells induce distinct patterns of chemokine production by normal and systemic sclerosis dermal fibroblastsArthritis research & therapy
accessLevelPublic
2006 516 196
Proteasome blockade exerts an antifibrotic activity by coordinately down-regulating type I collagen and tissue inhibitor of metalloproteinase-1 and up-regulating metalloproteinase-1 production in human dermal fibroblastsThe FASEB journal
accessLevelRestricted
2006 585 0
Combined antiviral-immunosuppressive treatment in human T-lymphotrophic virus 1-Sjögren-associated myelopathyArchives of neurology
accessLevelPublic
2006 640 478
Efficacy of TNF {alpha} blockade in cyclophosphamide resistant neuro-Behçet diseaseJournal of neurology, neurosurgery and psychiatry
accessLevelPublic
2005 547 163
Constitutive repressor activity of CD33 on human monocytes requires sialic acid recognition and phosphoinositide 3-kinase-mediated intracellular signalingEuropean Journal of Immunology
accessLevelPublic
2005 639 445
Mycobacterial lipoarabinomannans modulate cytokine production in human T helper cells by interfering with raft/microdomain signallingCellular and molecular life sciences
accessLevelPublic
2005 533 309
Vascular occlusion in serpiginous choroidopathyBritish journal of ophthalmology
accessLevelPublic
2005 571 104
Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis?Arteriosclerosis, thrombosis, and vascular biology
accessLevelPublic
2005 620 704
Nephrogenic fibrosing dermopathy in a renal transplant recipient with tubulointerstitial nephritis and uveitisDermatology
accessLevelRestricted
2004 483 0
Erythema elevatum et diutinum, multiple sclerosis and interferon betaDermatology
accessLevelPublic
2004 595 39
Diagnostic et prise en charge des pathologies rénales de l'enfantRevue médicale de la Suisse romande
accessLevelRestricted
2004 442 1
Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alphaArthritis and rheumatism
accessLevelPublic
2003 1,010 554
Thrombose des sinus veineux cérébraux dans la maladie de Behcet : description d'un cas et revue de la littératureKlinische Monatsblätter für Augenheilkunde
accessLevelRestricted
2003 549 0
Complete remission of pure white cell aplasia associated with thymoma, autoimmune thyroiditis and type 1 diabetesEuropean journal of haematology
accessLevelPublic
2003 668 99
Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosisArthritis and rheumatism
accessLevelPublic
2002 580 402
Anti-GAD antibodies and breast cancer in a patient with stiff-person syndrome: a puzzling associationEuropean neurology
accessLevelPublic
2001 568 349
Usefulness of serum eosinophil cationic protein (ECP) in predicting relapse of Churg and Strauss vasculitisClinical and Experimental Rheumatology
accessLevelRestricted
2000 431 0
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack